Introduction
Store-operated calcium entry (SOCE) is a mechanism for Ca 2+ influx controlled by the filling state of the intracellular Ca 2+ stores [1] . The activation of SOCE has been reported to involved the participation of the stromal interaction molecule-1 (STIM1) [2] [3] [4] , identified both as a membrane surface protein in stromal cells [5] , and, predominantly, in the membranes of the endoplasmic reticulum (ER) [6] and certain acidic Ca 2+ stores [7] . STIM1 located in the membrane of the internal Ca 2+ stores expresses the Ca 2+ binding domain (the EF hand motif) within the ER lumen. Hence, when the intraluminal Ca 2+ concentration decreases STIM1 re-localizes at sites of close proximity to the plasma membrane (PM) and the ER membrane, allowing its association with members of the Orai and TRPC families [8] [9] [10] . SOCE has been reported to be modulated by the Ca 2+ microdomains surrounding the elements of the SOCE machinery, both STIM1 and the store-operated channels (SOCs). Ca
2+
-dependent inactivation of SOCs is influenced by mitochondria, which, either directly or through the activation of ATP-dependent Ca 2+ clearance mechanisms [11] , is able to buffer Ca 2+ entering the cell [12] and STIM1 function is controlled by the intraluminal Ca 2+ concentration, which is finely modulated by the interplay between closely located sarco/ endoplasmic reticulum Ca 2+ ATPases [13, 14] and receptors for intracellular Ca
-mobilizing diffusible molecules. In mammalian cells, intracellular Ca 2+ mobilizing molecules include the inositol 1,4,5-trisphosphate (IP 3 ), cyclic ADP ribose or nicotinic acid adenine dinucleotide phosphate (NAADP). While a role for IP 3 and cyclic ADP ribose (ryanodine) receptors in the regulation of Ca 2+ influx has long been proposed [15] [16] [17] , a possible role for NAADP receptors in SOCE or other mechanisms for Ca 2+ influx is unknown. Three NAADP-regulated receptors/channels have been identified as two-pore channels (TPC), with TPC1 and TPC2 both mediating NAADP-induced Ca 2+ release, and TPC3, a pseudogene in humans and other primates [18, 19] . TPC1 is predominantly localized in endosomes while TPC2 has been mostly identified in lysosomerelated organelles [18, 20] , cellular compartments that have been presented as agonist-releasable Ca 2+ stores in different cell types [7, 21, 22] , with the ability to activate SOCE [23] . Despite, photoaffinity labeling of high affinity NAADP binding sites has demonstrated that this messenger molecule binds to an accessory protein rather than directly to TPCs both in mammalian cells [24] and sea urchin eggs [25] , NAADP is the only known physiological modulator of TPCs. In the present study we have investigated the possible role of TPC1 and TPC2 in SOCE in two unrelated mammalian cells, the megakaryoblastic cell line MEG01 and HEK-293. Our results indicate that, while TPC1 and TPC2 are expressed in both cell types, TPC1 knockdown was without effect in SOCE and silencing of TPC2 expression results in a significant attenuation of SOCE probably mediated by the interaction with STIM1 and Orai1, which suggest a functional role for TPC2 in the modulation of SOCE.
Materials and methods

Materials
Fura-2 acetoxymethyl ester (fura-2/AM) and calcein were from Invitrogen (Madrid, Spain). Thrombin, thapsigargin (TG), leupeptin, benzamidine, phenyl methyl sulphonyl fluoride (PMSF), sodium dodecyl sulfate (SDS), rabbit anti-Orai1 antibody (C-terminal), rabbit anti-TPC2 antibody, nonidet P-40 and bovine serum albumin (BSA) were from Sigma (Madrid, Spain). Mouse anti-STIM1 antibody was from BD Transduction Laboratories (Franklin Lakes, NJ, U.S.A.). Rabbit anti-TRPC1 polyclonal antibody was obtained from Antibodies-online GmbH (Aachen, Germany). Goat anti-TPC1 antibody, horseradish peroxidase-conjugated donkey anti-goat IgG antibody and horseradish peroxidase-conjugated goat anti-rabbit IgG antibody were from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Horseradish peroxidaseconjugated ovine anti-mouse IgG antibody (NA931) and hyperfilm ECL were from Amersham (Buckinghamshire, U.K.). Transpass COS/ 293 transfection reagent was from Izasa (Madrid, Spain). Protein A-agarose was from Upstate Biotechnology Inc. (Madrid, Spain). Enhanced chemiluminescence detection reagents were from Pierce (Cheshire, U. K.). All other reagents were of analytical grade.
Cell culture
The human megakaryoblastic cell line MEG01 and HEK-293 cells were obtained from ATCC (Manassas, VA, USA) and cultured at 37°C with a 5% CO2 in RPMI or DMEM media, respectively, supplemented with 10% fetal calf serum, 2 mM L-glutamine and 50 μg/mL gentamycin.
shRNA, complementary oligonucleotides corresponding to a TPC1 target sequence (5′-CGAGCTGTATTTCATCATGAA-3′), TPC2 target sequence (5′-CAGGTGGGACCTCTGCATTGA-3′) or scramble RNA (scRNA) as control (5′-AATTCTCCGAACGTGTCACGT-3′) were kindly provided by Dr. Patel and described previously [20] . Cells were transiently transfected with shRNA using the Amaxa Nucleofection system (for MEG01 cells) or transpass COS/293 transfection reagent (for HEK-293 cells), and used 1-3 d after transfection as previously described [7] .
Cell viability was assessed using calcein and trypan blue. For calcein loading, cells were incubated for 30 min with 5 μM calcein-AM at 37°C, centrifuged and the pellet was resuspended in fresh HBS. Fluorescence was recorded from 2 mL aliquots using a Cary Eclipse spectrophotometer (Varian Ltd, Madrid, Spain). Samples were excited at 494 nm and the resulting fluorescence was measured at 535 nm. The results obtained with calcein were confirmed using the trypan blue exclusion technique. 95% of the cells were viable in our preparations.
RT-PCR
Total RNA was extracted from MEG01 and HEK293 cells using TRIzol® reagent (Invitrogen, Carlsbad, CA) according to manufacturer specifications, and reverse-transcribed to single-strand cDNA using SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen, Carlsbad, CA). Single-strand cDNA products were directly used for PCR amplification performed with an Eppendorff Mastercycler® thermal cycler (Eppendorf AG, Hamburg-Eppendorf, Germany). PCR reagents were purchased from TAKARA (Takara Bio Inc., Otsu, Shiga, Japan). PCR products were obtained using the following cycling conditions: 96°C 2 min, followed by 35 cycles of 96°C 15 s, 56°C 25 s, 72°C 30 s, and finished with 72°C 10 min. The following primers were used to amplify human TPC (hTPC) cDNA transcripts; hTPC1_F: 5-ttctgtgttttgctttaggg-3 and hTPC1_R: 5-attccgcttccattagatcc-3: hTPC2_F: 5-gtttgacatggagagaa ccttgac-3 and hTPC2_R: 5-gatgaaaataactggcaatcagaacc-3 [20] . PCR products were separated by electrophoresis in 1.5% agarose gels (Roth, Germany) and the resulting bands were documented and subsequently isolated from gels using UltraClean® PCR Clean-Up Kit (MO BIO Laboratories Inc., Carlsbad, CA). The amplification of hTPC transcripts was confirmed by sequenciation of the PCR products (STAB-SAIUex, University of Extremadura, Spain).
Measurement of intracellular free calcium concentration ([Ca
Cells were loaded with fura-2 by incubation with 2 μM fura 2/AM for 45 min at 37°C. Coverslips with cultured cells were mounted on a perfusion chamber and placed on the stage of an epifluorescence inverted microscope (Nikon Diaphot T200, Melville, NY, USA) with image acquisition and analysis system for video microscopy (Hamamatsu Photonics, Hamamatsu, Japan). Cells were continuously superfused with HEPES-buffered saline containing (HBS in mM): 145 NaCl, 10 HEPES, 10 D-glucose, 5 KCl, 1 MgSO 4 , pH 7.45, and supplemented with 0.1% (w/v) BSA. Cells were alternatively excited with light from a xenon lamp passed through a high-speed monochromator (Polychrome IV, Photonics, Hamamatsu, Japan) at 340/380 nm. Fluorescence emission at 505 nm was detected using a cooled digital CCD camera (Hisca CCD C-6790, Hamamatsu, Japan) and recorded using Aquacosmos 2.5 software, (Hamamatsu Photonics, Hamamatsu, Japan). Ca 2+ entry was estimated using the integral of the rise in fura 2 fluorescence 340/380 nm ratio for 2 min after addition of CaCl 2 . Ca 2+ release was estimated using the integral of the rise in fura 2 fluorescence 340/380 nm ratio for 2 min after the addition of thrombin or TG [26] .
To calculate the initial rate of Ca 2+ elevation after the addition of Ca 2+ to the medium, the traces were fitted to the equation y = A+ KX, where K is the slope.
Immunoprecipitation and Western blotting
The immunoprecipitation and Western blotting were performed as described previously [27, 28] . Briefly, 500 μL aliquots of cell suspensions (5 × 10 6 cells/mL) were lysed with an equal volume of Nonidet P-40 buffer, pH 8, containing 274 mM NaCl, 40 mM Tris, 20% glycerol, 4 mM EGTA, 2% nonidet P-40, 2 mM Na 3 VO 4 , 2 mM PMSF, 100 μg/mL leupeptin and 10 mM benzamidine. Aliquots of cell lysates (1 mL) were immunoprecipitated by incubation with 2 μg of anti-hTRPC1 antibody, anti-STIM1 antibody or anti-Orai1 antibody and 25 μL of protein A-agarose overnight at 4°C on a rocking platform. The immunoprecipitates were resolved by 10% SDS-PAGE and separated proteins were electrophoretically transferred onto nitrocellulose membranes for subsequent probing. Blots were incubated overnight with 10% (w/v) BSA in tris-buffered saline with 0.1% Tween 20 (TBST) to block residual protein binding sites. Immunodetection of TPC1 and TPC2 was achieved using the anti-TPC1 and anti-TPC2 antibodies diluted 1:500 in TBST overnight. The primary antibody was removed and blots were washed six times for 5 min each with TBST. To detect the primary antibody, blots were incubated for 45 min with the appropriate horseradish peroxidase-conjugated secondary antibody diluted 1:10000 in TBST and then exposed to enhanced chemiluminiscence reagents for 5 min. Blots were then exposed to photographic films. The density of bands on the film was measured using scanning densitometry.
Biotinylation of membrane proteins
MEG01 cells and adherent monolayers of cultured HEK-293 cells grown in 75-cm 2 tissue culture dishes were washed three times with HBS (without added serum or protein). 3 mL of Söerscen's buffer, pH7.0 (16 mM-Na 2 HPO 4 and 114 mM-NaH 2 PO 4 ) and containing 2.5 mg EZ-Link sulfo-NHS-LC-biotin was added, and the cells were incubated at 4°C for 1 h. The biotinylation reaction was terminated by addition of Tris-base to a final concentration of 33 mM. Following biotinylation, cells were washed twice in Sörensen's buffer, disrupted using Nonidet P-40 buffer and sonicated. Cells were harvested by centrifugation (16000 × g, 5 min at 4°C). Samples were incubated with 25 μL streptavidin beads overnight at 4°C and resuspended in Laemmli's buffer for subsequent analysis by Western blotting.
Statistical analysis
Analysis of statistical significance was performed using Student's t-test. p b 0.05 was considered to be significant for a difference.
Results
TPC1 and TPC2 mRNA and protein are expressed in MEG01 and HEK293 cells
Two ubiquitously expressed TPC proteins have been described, TPC1 and TPC2. TPC3 has been presented as a pseudogene in humans and other primates [29, 30] and appears to be absent in certain mammalian cells [19] . To identify expression of TPC1 and TPC2 in MEG01 and HEK293 cells we carried out RT-PCR. Semi-quantitative RT-PCR showed a single PCR band for TPC1 and TPC2 indicating significant expression of their mRNA transcripts in the human cell lines MEG01 and HEK293 (Fig. 1A) . We have further investigated the protein expression of TPC1 and TPC2 in these cells. As shown in Fig. 1B and C, Western blotting of cell lysates with specific anti-TPC1 and TPC2 antibodies revealed the presence of both proteins in MEG01 and HEK293 cells.
Silencing TPC2 expression attenuates TG-induced Ca 2+ influx
While the role of IP 3 and ryanodine receptors on Ca 2+ influx has long been described [31] [32] [33] , the involvement of TPCs in the regulation of Ca 2+ fluxes across the PM remains unknown. We have investigated whether TPC1 and TPC2 channels modulate TG-evoked SOCE by silencing TPC1 and TPC2 expression. As shown in Fig. 2A , top panels, shTPC1 and shTPC2 reduced significantly the amount of these proteins detected in MEG01 cells by 81 and 77%, respectively, as compared with scRNA. Western blotting with anti-actin antibody revealed a similar amount of protein in all lanes ( Fig. 2A, bottom Similar results were found when we investigated the role of TPCs in agonist-evoked Ca 2+ mobilization in MEG01 cells. As shown in Fig. 3 ] i elevation after stimulation with thrombin was 0.0578 ± 0.0046 in control cells and 0.0431± 0.0042 in shTPC2-treated cells; Fig. 3C ; p b 0.05; n =6. In contrast, and in agreement with the results reported for TG, TPC1 silencing was without effect on thrombin-evoked Ca 2+ entry (the initial slope of [Ca 2+ ] i elevation after stimulation with thrombin was 0.0591±0.0039 in shTPC1-treated cells; Fig. 3B ; n =6).
To confirm the findings observed in MEG01 cells we investigated the effect of TPC1 and TPC2 silencing in TG-induced SOCE in HEK293 cells. Treatment of HEK293 cells with 1 μM TG resulted in a sustained increase in [Ca 2+ ] i due to Ca 2+ leak from the intracellular ] i upon Ca 2+ addition (the initial slope was 0.0211 ±0.0027 in shTPC2-treated cells; Fig. 4B ; p b 0.05; n =6).
TPC1 and TPC2 are not expressed in the plasma membrane
To investigate whether the modulatory effect of TPC2 on SOCE and agonist-stimulated Ca 2+ entry is mediated by their presence in the PM, we assessed the surface expression of TPC1 and TPC2 in resting MEG01 and HEK293 cells by biotinylation of PM proteins and collection with streptavidin-coated agarose beads. SDS-PAGE and Western blotting were used to identify TPC1, TPC2 and Orai1, a SOC subunit located in the PM [34, 35] determined as positive control. As shown in Fig. 5 , analysis of biotinylated proteins shows that Orai1 is present in the PM in resting MEG01 and HEK-293 cells. In contrast, we were unable to detect TPC1 and TPC2 in the PM under the same experimental conditions ( Fig. 5 ; n =4); thus indicating that TPC1 and TPC2 are expressed in the membrane of internal organelles, as previously described [18, 36, 37] .
TPC2 co-immunoprecipitates with STIM1 and Orai1 but not with TRPC1 in MEG01 cells
In order to explore the mechanism underlying the modulation of SOCE by TPC2 we investigated its association with STIM1, Orai1 and TRPC1 by looking for co-immunoprecipitation from MEG01 lysates. Immunoprecipitation and subsequent SDS/PAGE and Western blotting were conducted using resting cells and cells in which the intracellular Ca 2+ stores had been depleted by 3 min of pretreatment with TG
(1 μM) in the absence of extracellular Ca 2+ (100 μM EGTA). After immunoprecipitation with the anti-STIM1 antibody, Western blotting revealed the presence of TPC2 in samples from store-depleted, but not resting cells (Fig. 6B , top panel; n = 5), while TPC1 was undetectable in samples from either resting or store-depleted cells (Fig. 6A , top panel; n = 5), which is consistent with a role for TPC2, but not TPC1, in the regulation of SOCE, as reported above. Western blotting with anti-STIM1 antibody confirmed a similar content of this protein in all lanes ( Fig. 6A and B, bottom panels). We also conducted experiments on immunoprecipitating MEG01 cell lysates under resting or TGstimulated conditions with either anti-Orai1 or anti-TRPC1 antibody.
After immunoprecipitation with anti-Orai1, TPC2 was detected in samples from store-depleted, but not resting MEG01 cells (Fig. 6C , top panel; n =5); however, after immunoprecipitation with anti-TRPC1 TPC2 was undetectable in samples from control or TG-treated samples (Fig. 6D , top panel; n= 5). Immunoblot analysis of anti-Orai1 or anti-TRPC1 immunoprecipitates with the same antibodies, as appropriate, revealed a similar content of these proteins in the relevant lanes ( Fig. 6C and D, bottom panels; n =5).
Discussion
Cytosolic Ca 2+ concentration is modified by a vast number of agonists in order to regulate cellular function. Agonist-receptor interaction leads to the generation of distinct intracellular Ca
2+
-releasing molecules, among them, NAADP has been identified as the most potent Ca 2+ -mobilizing messenger described [38, 39] . NAADP has been reported to regulate different ion channels, including the type I ryanodine receptor [40] and TRP-ML1 (transient receptor potential channel, subtype mucolipin 1) [41] . More recently, a number of studies demonstrated that TPCs are NAADP-regulated Ca 2+ channels [18, 20, 42] . TPCs are located in endosomes and lysosome-related organelles, although TPC2 has been reported as the major lysosomal targeted isoform [43] . SOCE is a receptor-operated Ca 2+ influx mechanism controlled by the amount of Ca 2+ accumulated into agonistsensitive compartments, mostly described as the ER and lysosomalrelated (acidic) organelles [23, 44] , both expressing the Ca 2+ sensor STIM1 [3, 7] . However, despite SOCE is activated by discharge of the lysosomal-related organelles, where Ca 2+ efflux via the TPCs/NAADP has been demonstrated in the ER, endosomes and lysosomal-related organelles [45] . We have further found that silencing TPC2, but not TPC1, expression reduces Ca 2+ entry by the physiological agonist thrombin. The lack of effect of alternative silencing of TPC1 and TPC2 expression on thrombin-stimulated Ca 2+ release might be attributed to different factors: i) thrombin is unable to generate significant amounts of NAADP to induce a detectable signal; ii) the effect of the attenuation of TPC1 or TPC2 expression on thrombin-evoked Ca release is overcome by the actions of other intracellular channels, including the IP 3 or ryanodine receptors (MEG01 cells have been reported to express IP 3 receptors types I, II and III [46] and the type III ryanodine receptor [47] ). We have explored the mechanism underlying the modulation of SOCE by TPC2 and tested the presence of TPCs in the PM, where the SOCs are located. Biotinylation analysis confirmed that TPCs are not expressed in the PM. Our results also report for the first time that discharge of the intracellular Ca 2+ stores using TG leads to the association of TPC2 with the Ca 2+ sensor STIM1 and Ca 2+ channel Orai1; however, we did not detect association of TPC2 with TRPC1. The interaction of TPC2 with STIM1 and Orai1 was only found in cells where the Ca 2+ stores had been depleted using TG and not in resting, undepleted, cells, which suggest that this is a de novo association whose activation shows parallelism with that of SOCE. The association of TPC2 with STIM1 upon store depletion strongly suggests that TPC2 plays a relevant role in the regulation of SOCE. Although speculative, rapid Ca 2+ efflux mediated by TPC2 in the close proximity of STIM1 might influence the rate and extent of SOCE activation by the latter, which would explain the attenuation of the initial rate and extent of SOCE found upon silencing TPC2 expression. The TPC2-Orai1 association might occur either directly or indirectly and mediated by STIM1, and this interaction might also be important for the regulation of SOCE by TPC2. The involvement of TPC2, but not TPC1, in the modulation of SOCE might be attributed to the distinct distribution of TPCs in human cells, with TPC2 predominantly located in lysosomal-related organelles [18, 20, 43] . In addition, relevant functional differences between TPC1 and TPC2 have been described. While Ca 2+ release through both receptor/channels are regulated by NAADP, the subsequent amplification of this Ca 2+ signal by IP 3 receptors, which are also involved in the regulation of SOCE [48] , is more tightly coupled for TPC2 [29] . Our findings provide the first evidence for a role for TPC2 in the modulation of SOCE. The new role of TPC2 might be mediated by colocalization with STIM1 in internal stores, which might modify the kinetics of STIM1-Ca 2+ binding and, thus, Ca 2+ sensing and the activation rate and extent of SOCE.
